Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective

about

Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective

Item

http://www.wikidata.org/entity/Q58737780

description

article

@en

im Juni 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective

@en

Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective

@nl

type

Item

label

Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective

@en

Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective

@nl

prefLabel

Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective

@en

Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective

@nl

P1476

Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective

@en

P2093

James W McBlane

http://www.w3.org/2001/XMLSchema#string

Michaela Sharpe

http://www.w3.org/2001/XMLSchema#string

Parvinder Phul

http://www.w3.org/2001/XMLSchema#string

P2860

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Translating stem cell therapies: the role of companion animals in regenerative medicine

Embryonic stem cell lines derived from human blastocysts

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.

Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening.

Inhibition of pluripotent stem cell-derived teratoma formation by small molecules

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.

P304

165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-018-2437-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29943208

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

molecular medicine

biotechnology

P932

6156759

http://www.w3.org/2001/XMLSchema#string